Dr. Austin Harris, MD, founder of NeuroRelief Ketamine & Infusion Therapy, has announced the availability of NAD+ IV infusion ...

Intravenous lidocaine infusions for chronic pain are associated with a low incidence of serious adverse events, according to recent study results.

This as-told-to essay is based on a conversation with Mary Youssef, a mobile IV infusion therapist, about her career path. It has been edited for length and clarity. Five days a week, I probe the arm ...

Viridian Therapeutics (VRDN) on Saturday launched its first commercial product, Lumvoa, soon after the U.S. FDA approved the intravenous therapy for thyroid eye disease, a rare autoimmune disease ...

Results of a new meta-analysis show that intravenous fluid (IV) therapy using balanced solutions rather than commonly used saline can reduce the risk of in-hospital death of critically ill patients by ...

As part of a multidisciplinary team effort, Bayhealth, Exceptional Care for Children and the State of Delaware have designed a community health program to provide education on central venous access ...